Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CITED2 | FIMM | pan-cancer | AAC | 0.47 | 0.005 |
mRNA | FGF7 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
mRNA | UNC13D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | CEP41 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
mRNA | DNAJC24 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | FRMPD4 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
mRNA | PHF21A | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
mRNA | RRM1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | NPM2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | SUPT16H | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |